Issue 8, 2016

Design, synthesis and antiproliferative activity studies of 1,2,3-triazole–chalcones

Abstract

A series of 1,2,3-triazole–chalcone hybrids were designed, synthesized and evaluated for their antiproliferative activity against three selected cancer cell lines (SK-N-SH, HepG-2 and MGC-803). Most of the synthesized compounds exhibited moderate to good activity against all the cancer cell lines selected. Particularly, compound 12k showed the most excellent antiproliferative activity with an IC50 value of 1.53 μM against SK-N-SH cancer cells. The mechanism studies revealed that compound 12k inhibited the proliferation of SK-N-SH cancer cells by inducing apoptosis and arresting the cell cycle at the G1 phase.

Graphical abstract: Design, synthesis and antiproliferative activity studies of 1,2,3-triazole–chalcones

Associated articles

Supplementary files

Article information

Article type
Research Article
Submitted
23 Mar 2016
Accepted
17 Jun 2016
First published
20 Jun 2016

Med. Chem. Commun., 2016,7, 1664-1671

Design, synthesis and antiproliferative activity studies of 1,2,3-triazole–chalcones

D. Fu, S. Zhang, Y. Liu, X. Yue, J. Liu, J. Song, R. Zhao, F. Li, H. Sun, Y. Zhang and H. Liu, Med. Chem. Commun., 2016, 7, 1664 DOI: 10.1039/C6MD00169F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements